| Page 2001 | Kisaco Research
 
CAR-T Congress USA
20-22 Mar 2018
Boston, USA
The CAR-T Congress gathers thought leaders from biotech, big pharma, academia and investment to address the challenges and opportunities of CAR-T therapies in both liquid and solid tumors. Discussing the potential of CARs in alternative cell types, mechanisms behind toxicity and tumor targeting, this event will provide an in depth view into this expansive area.
Visit Site
 

Dr Noushin Dianat

CEO
Cyprio

Being a liver bioengineering enthusiast, in 2014, Noushin joined Laboratory of Colloids and Divided Materials (LCMD) at ESPCI Paris (The City of Paris Industrial Physics and Chemistry Higher Educational Institution) as a postdoctoral fellow and developed a novel 3D liver model adapted for high throughput drug screening through a collaborative project with Sanofi.

Read full bio

Dr Noushin Dianat

CEO
Cyprio

Dr Noushin Dianat

CEO
Cyprio

Being a liver bioengineering enthusiast, in 2014, Noushin joined Laboratory of Colloids and Divided Materials (LCMD) at ESPCI Paris (The City of Paris Industrial Physics and Chemistry Higher Educational Institution) as a postdoctoral fellow and developed a novel 3D liver model adapted for high throughput drug screening through a collaborative project with Sanofi.

 

Gianni Dal Negro

CIVM Diector, Integrated Biological Platform Sciences
GSK

Gianni Dal Negro

CIVM Diector, Integrated Biological Platform Sciences
GSK

Gianni Dal Negro

CIVM Diector, Integrated Biological Platform Sciences
GSK
Poster Submission Form